Publications by authors named "David Andrae"

Claim this Profile
P
Psychometric validation of the Pyruvate Kinase Deficiency Diary and Pyruvate Kinase Deficiency Impact Assessment in adults in the phase 3 ACTIVATE trial.
David A Andrae, Rachael F Grace, Adrian Jewett, Brandon Foster, Robert J Klaassen

J Patient Rep Outcomes· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of raw and regression approaches to capturing change on patient-reported outcome measures.
David A Andrae, Brandon Foster, J Devin Peipert

Qual Life Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychometric evaluation of the Urgency NRS as a new patient-reported outcome measure for patients with ulcerative colitis.
Marla C Dubinsky, Mingyang Shan, Laure Delbecque, Trevor Lissoos, Theresa Hunter, David Andrae

J Patient Rep Outcomes· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Memory-Assisted Global Impression of Change (MAGIC).
Linda S Deal, David A Andrae, Daniela E Myers, Christopher Dell, Nathan Johnson

Ther Innov Regul Sci· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Measurement Performance of the Parkinson's Disease Activities of Daily Living, Interference, and Dependence Instrument.
Linda S Deal, David A Andrae, Daniela E Myers, Nathan Johnson, Brandon Foster

Front Neurol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of the Presbyopia Impact and Coping Questionnaire.
Nathan Johnson, Elaheh Shirneshan, Cheryl D Coon, Jonathan Stokes, Ted Wells, David A Andrae

Ophthalmol Ther· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of the Near Vision Presbyopia Task-based Questionnaire for use in evaluating the impact of presbyopia.
Elaheh Shirneshan, Cheryl D Coon, Nathan Johnson, Jonathan Stokes, Ted Wells, David A Andrae

J Patient Rep Outcomes· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the Overactive Bladder-Bladder Assessment Tool (OAB-BAT): A Potential Alternative to the Standard Bladder Diary for Monitoring OAB Outcomes.
Christopher Chapple, Con Kelleher, Emad Siddiqui, David A Andrae, Nathan Johnson

Eur Urol Focus· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Initial Validation Analyses of the Living with Idiopathic Pulmonary Fibrosis Questionnaire.
Jeffrey J Swigris, David A Andrae, Tara Churney, Nathan Johnson, Mary Beth Scholand

Am J Respir Crit Care Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of treatment with eluxadoline on abdominal pain in patients with IBS-D: Additional post hoc analyses of Phase 3 trials.
Anthony J Lembo, Paul S Covington, Leonard S Dove, David A Andrae

Neurogastroenterol Motil· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation and Validation of the Modified Reflux Symptom Questionnaire-Electronic Diary in Patients With Persistent Gastroesophageal Reflux Disease.
David A Andrae, Jennifer Hanlon, Mary Lynn Cala, Kayla Scippa, Christina Graham

Clin Transl Gastroenterol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of treatment with eluxadoline on health-related quality of life among adult patients with irritable bowel syndrome with diarrhea.
Jessica L Abel, Robyn T Carson, David A Andrae

Qual Life Res· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic burden of inadequate symptom control among US commercially insured patients with irritable bowel syndrome with diarrhea.
Jessica L Buono, Kush Mathur, Amelia J Averitt, David A Andrae

J Med Econ· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Burden of Irritable Bowel Syndrome with Diarrhea: Retrospective Analysis of a U.S. Commercially Insured Population.
Jessica L Buono, Kush Mathur, Amelia J Averitt, David A Andrae

J Manag Care Spec Pharm· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eluxadoline for Irritable Bowel Syndrome with Diarrhea.
Anthony J Lembo, Brian E Lacy, Marc J Zuckerman, Ron Schey, Leonard S Dove, David A Andrae

N Engl J Med· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Item-level assessment of the irritable bowel syndrome quality of life questionnaire in patients with diarrheal irritable bowel syndrome.
David A Andrae, Paul S Covington, Donald L Patrick

Clin Ther· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients.
David A Andrae, Donald L Patrick, Douglas A Drossman, Paul S Covington

Health Qual Life Outcomes· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 2 study of the novel fluoroquinolone JNJ-Q2 in community-acquired bacterial pneumonia.
Paul S Covington, J Michael Davenport, David A Andrae, Martin E Stryjewski, Lisa L Turner

J Antimicrob Chemother· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
Leonard S Dove, Anthony Lembo, Charles W Randall, Ronald Fogel, David Andrae

Gastroenterology· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, double-blind, phase II, multicenter study evaluating the safety/tolerability and efficacy of JNJ-Q2, a novel fluoroquinolone, compared with linezolid for treatment of acute bacterial skin and skin structure infection.
Paul Covington, J Michael Davenport, David Andrae, William O'Riordan, Lisa Liverman

Antimicrob Agents Chemother· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis